(S)-80-((tert-Butoxycarbonyl)amino)-74-oxo-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71-tetracosaoxa-75-azahenoctacontan-81-oic acid

Catalog No. :
ACPYQZ958
CAS No. :
2353409-83-1
Molecular Formula :
C61H120N2O29
Molecular Weight :
1345.62

IUPAC Name:(S)-80-((tert-butoxycarbonyl)amino)-74-oxo-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71-tetracosaoxa-75-azahenoctacontan-81-oic acid

(S)-80-((tert-Butoxycarbonyl)amino)-74-oxo-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71-tetracosaoxa-75-azahenoctacontan-81-oic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$500.00Login to see priceInquiryInquiry
250mg97%$961.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-80-((tert-Butoxycarbonyl)amino)-74-oxo-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71-tetracosaoxa-75-azahenoctacontan-81-oic acid
IUPAC Name(S)-80-((tert-butoxycarbonyl)amino)-74-oxo-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71-tetracosaoxa-75-azahenoctacontan-81-oic acid
Molecular FormulaC61H120N2O29
Molecular Weight1345.62
SMILESO=C(O)[C@@H](NC(OC(C)(C)C)=O)CCCCNC(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O
InChI KeyWGKYSHPOTCOWIY-SMWREMLRSA-N
SynonymN-Boc-N'-(mPEG24)-L-Lysine-OH
CAS No.2353409-83-1

Synthetic Route by SureRoute

1. ACPYQZ958 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYQZ958 route product structure diagram
    ACPYQZ9582353409-83-1
Inquiry

2. ACPYQZ958 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYQZ958 route product structure diagram
    ACPYQZ9582353409-83-1
Inquiry

Comments (0)